HB 1481 – Sickle Cell Disease Medications, Treatment, and Screening
Requires certain health care providers to notify primary care physicians of newborns and infants about specific screening results related to sickle cell hemoglobin variants and to submit these results to the DOH for a specified purpose.
HB 1481 – Sickle Cell Disease Medications, Treatment, and Screening Read More »